Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The International Journal of Tuberculosis and Lung Disease

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16104645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis.

  2004cited by this paper
• Tetrazolium Microplate Assay as a Rapid and Inexpensive Colorimetric Method for Determination of Antibiotic Susceptibility of Mycobacterium tuberculosis

  2002cited by this paper
• Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay

  1998cited by this paper
• [New microbiological Techniques in diagnosis of tuberculosis].

  1996cited by this paper
• New microbiological Techniques in diagnosis of tuberculosis

  1996cited by this paper
• Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

  1995cited by this paper
• Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method

  1995cited by this paper
• Antimicrobial Agents and Susceptibility Testing

  1990cited by this paper
• Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis

  1981cited by this paper
• MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

  1963cited by this paper

• Evaluation of Colorimetric Nitrate Reductase Assay in Liquid Medium for Detection of Resistance to First-line Antitubercular Drugs.

  2024cites this paper
• Nitrate Reductase Assay for Rapid Determination of Methicillin-Resistant Staphylococcus aureus Clinical Isolates.

  2023cites this paper
• Novel azoles with potent antileishmanial activity.

  2021cites this paper
• Resazurin assay for rapid drug susceptibility testing of Mycobacterium tuberculosis

  2020cites this paper
• A Novel Class of Azoles with potent Anti-Leishmanial activity

  2020cites this paper
• Engineering a CRISPR Interference System To Repress a Class 1 Integron in Escherichia coli

  2019cites this paper
• Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN−/− mutant

  2018cites this paper
• Synthesis and antimycobacterial activity evaluation of isatin-derived 3- [(4- aryl - 2- thiazolyl])hydrazone]-1h- indol- 2, 3- diones

  2017cites this paper
• Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China

  2017cites this paper
• Screening of Fruits of Seven Plants Indicated for Medicinal Use in Iraq

  2017cites this paper
• Rapid drug-susceptibility testing of Mycobacterium tuberculosis clinical isolates to first-line antitubercular drugs by nitrate reductase assay: A comparison with proportion method

  2016cites this paper
• COMPARISON OF CONVENTIONAL METHOD, RADIOMETRIC METHOD AND METHOD USING OXIDATION-REDUCTION DYE FOR DETECTION OF MULTI DRUG RESISTANT TUBERCULOSIS

  2015cites this paper
• Evaluation of the Performance of Nitrate Reductase Assay for Rapid Drug-Susceptibility Testing of Mycobacterium Tuberculosis in South Gujarat Region

  2015cites this paper
• Synthesis, Antituberculotic, and Cytotoxic Properties of New Hydrazone Derivatives Bearing Pyrimidine-Alkylsulfanyl Moiety

  2015cites this paper
• Mycobacterium tuberculosis is resistant to streptolydigin.

  2013cites this paper
• Evaluation of rapid low-cost colorimetric methods for diagnosis of multidrug-resistant tuberculosis in limited-resource settings

  2013cites this paper
• Asociación entre la evolución clínica de pacientes con tuberculosis y la resistencia al tratamiento de los aislados de Mycobacterium Association between the clinical course of patients with tuberculosis and the treatment resistance of isolates of Mycobacterium

  2012cites this paper
• Antitubercular In Vitro Drug Discovery: Tools for Begin the Search

  2012cites this paper
• Rapid Determination of Methicillin Resistance among Staphylococcus aureus Clinical Isolates by Colorimetric Methods

  2012cites this paper
• BREVE Utility of nitrate reductase assay for detection of multidrug-resistant Mycobacterium tuberculosis in a low resource setting

  2012cites this paper
• Utility of nitrate reductase assay for detection of multidrug-resistant Mycobacterium tuberculosis in a low resource setting.

  2011cites this paper
• Identification of Mycobacterium tuberculosis genes preferentially expressed during human infection.

  2011cites this paper
• A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.

  2011cites this paper
• DOCKING, SYNTHESIS AND ANTITUBERCULAR EVALUATION OF ISONICOTINOYL HYDRAZINO - AMINO ACIDS

  2011cites this paper
• Application of the Alamar blue assay to determine the susceptibility to anti-tuberculosis pharmaceuticals

  2011cites this paper
• Evaluation of the Performance of Nitrate Reductase Assay for Rapid Drug-susceptibility Testing of Mycobacterium tuberculosis in North India

  2011influential citation
• Pharmacologyonline 2 : 601-628 ( 2010 ) ewsletter

  2010cites this paper
• EW DIAGOSTIC METHODS OF TUBERCULOSIS: FEASIBILITY AD APPLICABILITY ITHE FIELD

  2010cites this paper
• Rapid detection of drug resistance and genetic characterisation of Mycobacterium tuberculosis isolates in Honduras

  2010cites this paper
• Evaluation of Nitrate Reductase Assay (NRA) for rapid detection of druc resistant tuberculosis at National Tuberculosis Centre, Nepal

  2010cites this paper
• Antimycobacterial activity in vitro of pigments isolated from Antarctic bacteria

  2010cites this paper
• IDENTIFICATION OF THE FUNCTION OF RV0194 IN MYCOBACTERIUM TUBERCULOSIS by RACHEL PHILPOTT MICHAEL NIEDERWEIS, COMMITTEE CHAIR ASIM BEJ

  2009influential citation
• Drug-susceptibility testing in TB: current status and future prospects

  2009cites this paper
• Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB

  2008cites this paper
• The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

  2008cites this paper
• Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosis

  2008cites this paper
• Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs

  2008cites this paper
• Programmatic implementation of rapid DST for Mycobacterium tuberculosis in Peru.

  2008cites this paper
• Consideraciones sobre la implementación de nuevas herramientas diagnósticas en las redes de laboratorios de tuberculosis de Latinoamérica

  2007cites this paper
• Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods.

  2007cites this paper
• Recent Advances in Methodologies for the Discovery of Antimycobacterial Drugs

  2007cites this paper
• Microscopic-observation drug-susceptibility assay for the diagnosis of TB.

  2006cites this paper
• Drug susceptibility of the Mycobacterium genus: in vitro tests and clinical implications.

  2006cites this paper
• Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay.

  2005cites this paper